Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill shows promise in battling Hard-to-Treat cancers

NCT ID NCT05867251

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 37 times

Summary

This study tests a new oral drug, AVZO-021, in people with advanced solid tumors that have not responded to other treatments. The goal is to find safe doses and see if the drug can shrink tumors or slow cancer growth. The trial includes patients with certain breast, ovarian, and endometrial cancers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Care Wollongong

    RECRUITING

    Wollongong, New South Wales, Australia

    Contact

  • Florida Cancer Specialists

    RECRUITING

    Sarasota, Florida, 34232, United States

    Contact

  • Macquarie University Hospital

    RECRUITING

    Macquarie University, New South Wales, Australia

    Contact

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact

  • NEXT Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

  • NYU Langone Medical Center (Tisch Hospital)

    RECRUITING

    New York, New York, 10016, United States

    Contact

  • Oklahoma University

    RECRUITING

    Oklahoma City, Oklahoma, 73117, United States

    Contact

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island

    RECRUITING

    Mineola, New York, 11501, United States

    Contact

  • Providence Cancer Institute

    RECRUITING

    Portland, Oregon, 97213, United States

    Contact

  • Sidney Kimmel Cancer Center (SKCC) at Jefferson Health

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

    Contact

  • Texas Oncology - DFW

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

    Contact

  • Yale Cancer Center

    RECRUITING

    New Haven, Connecticut, 06520, United States

    Contact

Conditions

The condition(s) this trial relates to.

breast neoplasm Carcinoma, Ovarian Epithelial endometrium neoplasm fallopian tube neoplasm hormone receptor-positive breast cancer triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.